To determine whether checkpoint immunotherapy altered the expression of PNAd on tumor vasculature, we treated I.P. tumor-bearing WT mice with either anti-PD-L1 monotherapy or the combination of anti-CTLA4 and anti-PD1 and analyzed PNAd expression after 14 days of outgrowth. The gene discussed is CD274; the disease is neoplasm.